Rewarding value creation to promote innovation in oncology: The importance of considering the global product life cycle.
Department of Pharmacy, University of Washington, Seattle, USA. lgarrisn@uw.edu
Louis P
LP
Garrison
D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000191:economics / Q000628:therapy; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D007348:Insurance, Health / Q000191:economics; D008495:Medical Oncology; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics*; D009936:Organizational Innovation; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab